These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19938083)

  • 1. Journal of Pharmaceutical Sciences. Editorial.
    Borchardt RT
    J Pharm Sci; 2010 Feb; 99(2):567. PubMed ID: 19938083
    [No Abstract]   [Full Text] [Related]  

  • 2. Journal of Pharmaceutical Sciences. Editorial.
    Borchardt RT
    J Pharm Sci; 2010 Aug; 99(8):3279-80. PubMed ID: 20552649
    [No Abstract]   [Full Text] [Related]  

  • 3. Timely reminder.
    Singh B
    Aust N Z J Psychiatry; 2005 Mar; 39(3):202-3. PubMed ID: 15701072
    [No Abstract]   [Full Text] [Related]  

  • 4. Three million HIV/AIDS sufferers could receive anti-retroviral therapy by 2005: new hope for those in developing world.
    Lepr Rev; 2002 Sep; 73(3):295-6. PubMed ID: 12449898
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV research and access to treatment.
    Warren M
    Science; 2006 Jan; 311(5758):175-6; author reply 175-6. PubMed ID: 16410505
    [No Abstract]   [Full Text] [Related]  

  • 6. New guidelines increase access to HIV/AIDS medication.
    AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
    [No Abstract]   [Full Text] [Related]  

  • 7. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 8. European Parliament supports treatment access in developing countries.
    James JS
    AIDS Treat News; 2001 Mar; (363):4-5. PubMed ID: 11547677
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: the reality of treating HIV and AIDS in poor countries.
    Sykes R
    BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical industry's corporate social responsibility towards HIV/AIDS.
    Khanna AK
    J Postgrad Med; 2006; 52(3):194-6. PubMed ID: 16855320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries.
    Vento S; Lanzafame M; Lattuada E; Cainelli F; Restelli U; Foglia E
    Trop Med Int Health; 2013 Jan; 18(1):40-4. PubMed ID: 23094787
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

  • 13. Cooperation forms to accelerate access to AIDS care in developing countries.
    AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
    Piot P
    N Engl J Med; 1998 Mar; 338(12):839; author reply 840-1. PubMed ID: 9508637
    [No Abstract]   [Full Text] [Related]  

  • 15. Access for all?
    Lange JM; Thaineua V
    Science; 2004 Jun; 304(5679):1875. PubMed ID: 15218109
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the AIDS Impact Conference: the post-AIDS era and the effect of treatment advances.
    DeCarlo P; Grinstead O
    Focus; 1999 Oct; 14(11):1-4. PubMed ID: 11366893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal access to HIV/AIDS treatment: challenges ahead.
    Satyanarayana K; Srivastava S
    Indian J Med Res; 2009 Dec; 130(6):671-4. PubMed ID: 20090125
    [No Abstract]   [Full Text] [Related]  

  • 18. A record 6.6 million patients in poor countries received antiretroviral treatment in 2010.
    Zarocostas J
    BMJ; 2011 Jun; 342():d3555. PubMed ID: 21646311
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to HIV drugs should be widened, says WHO.
    Gulland A
    BMJ; 2013 Jul; 347():f4172. PubMed ID: 23818559
    [No Abstract]   [Full Text] [Related]  

  • 20. Opportunities for preventing HIV in treatment settings in developing countries.
    Lurie MN; Akileswaran C; Mayer KH
    Lancet Infect Dis; 2005 Feb; 5(2):66-8. PubMed ID: 15680769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.